|
The Pharmaceutical Industry's Power
KIERAN Schneemann and the pharmaceutical industry lobby group Medicines Australia (Letters, 18/1) choose to evade the influence the pharmaceutical industry has on drug policy in the US and their encroachment into policy here in Australia through the Australia-US free trade agreement. The Pharmaceutical Benefits Scheme has traditionally had the interests of the Australian population and public health guidelines as its basis - not rewarding so-called "innovation" of the pharmaceutical industry. Subjecting the PBS to a trade agreement has been a backward step for health policy in Australia. Dr Tracy Schrader, national vice-president, Doctors Reform Society
The Age 20/01/06
|
[ Doctors Reform Society of Australia
home page] |